Medical Updates

Effect of Different Medications on Fracture Risk in RA Patients

A recent longitudinal observational cohort study investigated the impact of use of disease-modifying antirheumatic drugs (DMARDs), statins, proton...

30 Jul, 2019

 
Email this page
Zoledronic Acid, A New Paradigm in the Management of Transient Osteoporosis of Hip

Transient osteoporosis of hip (TOH) is a self-limiting idiopathic condition and requires 6-12 months for the resolution of symptoms. There is...

25 Jul, 2019

 
Email this page
Short-term Daily Teriparatide Improved Functional Outcomes and Fracture Healing in Intertrochanteric Fractures

Osteoporotic hip fracture is a serious medical problem with a significant burden on the healthcare system. Use of osteoanabolic agents for...

09 Jul, 2019

 
Email this page
Effect of Concurrent Use of MTX on TCZ Retention in RA Patients

Active rheumatoid arthritis (RA) patients with and without renal insufficiency (the ACTRA-RI study) is an ongoing multicentre cohort consisting of...

05 Jul, 2019

 
Email this page

Key Trials

Effect of Teriparatide Treatment on Mesenchymal Stromal Cells Functionality in Postmenopausal Osteoporotic Women with Atypical Femoral Fractures

Prevalence of atypical femoral fractures (AFF) induced by long-term treatment with bisphosphonates, ranges between 3.22 and 113.1 cases per 100,000...

Adalimumab Treatment Demonstrates Long-term Safety Profile in Japanese Patients with RA

This study determined the incidence of adverse drug reactions (ADRs) and factors associated with the safety and efficacy of adalimumab in Japanese...

Continuing versus Withdrawing Adalimumab Therapy in Patients with Active Non-radiographic Axial Spondyloarthritis

ABILITY-3 study is a randomized controlled trial evaluating the safety and efficacy of continuing versus withdrawing adalimumab therapy in patients...

Post-Hip Fracture, Alendronate Treatment is Associated with Reduced Cardiovascular Risk

This is the first large contemporary analysis of real-world clinical practice that compared the risk of cardiovascular events among hip fracture...

Patient Education

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE) is an inflammatory disease caused when the immune system attacks body’s own tissues. This leaflet gives an overvie...

Food Rich in Calcium and Vitamin D

Eating foods rich in calcium and vitamin D may help prevent bones from becoming weak and less likely to fracture.  This article gives a list of food...

Calcium – Vitamin D Recommended Dietary Allowance

Calcium and vitamin D are two essential nutrients long known for their roles in maintaining bone health. This article gives comprehensive recommended...

Our Publications

Risofos Kit (Risedronate, Calcium citrate malate, Vitamin D3) – Data Sheet

This datasheet covers the rationale for Risofos kit formulation, its composition, dosage and administration information.

Calcinase (calcitonin) – Monograph

This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...

Imutrex (methotrexate) – Getting to the Heart of Rheumatoid Arthritis Abstracts Booklet

This publication features efficacy & safety studies of methotrexate in management of rheumatoid arthritis.

Risofos 150 (Risedronate) – Monograph

Risendronate 150 mg is used for the management of osteoporosis. This monograph provides information on its basic pharmacology, clinical efficacy...

Slide Library

Intraarticular Hyaluronic acid for Osteoarthirits

The presentation includes description of synovial hyaluronic acid, its viscoelastic property, mechanism of action and different types available in...

 
Email this page
Osteoarthritis

This presentation shows the structure of bone joint majorly affected in osteoarthritis, its pathophysiology, risk factors, signs and symptoms and...

 
Email this page
Recommendations for Up & Downscaling of Methotrexate Dose in Rheumatoid Arthritis

Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...

 
Email this page
Musculoskeletal Manifestations of Ulcerative Colitis

This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...

 
Email this page

Poll

Which of the following bisphosphonate is preferred as first line treatment of osteoporosis-
Alendronate
75% (3 votes)
Risedronate
0% (0 votes)
Ibandronate
0% (0 votes)
Zoledronic acid
25% (1 vote)
Total votes: 4